Olafsson Sigurdur O
Insider CIK 1499481 · PFNX Director · MNK President and CEO, Director · ACT PRES.-ACTAVIS PHARMA, Director · WPI Pres.-Global Generics
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NONE Keenova Therapeutics plc | A Award deriv | 2026-02-25 | 2026-02-26 | 198,539 | — | $0 | 506,815 | SEC↗ |
| NONE Keenova Therapeutics plc | M Exercise deriv | 2026-01-01 | 2026-01-05 | 32,878 | — | $0 | 308,276 | SEC↗ |
| NONE Keenova Therapeutics plc | F Tax w/h | 2026-01-01 | 2026-01-05 | 16,939 | — | $0 | 31,718 | SEC↗ |
| NONE Keenova Therapeutics plc | M Exercise | 2026-01-01 | 2026-01-05 | 32,878 | — | $0 | 48,657 | SEC↗ |
| NONE Mallinckrodt plc | A Award deriv | 2025-08-14 | 2025-08-18 | 65,005 | — | $0 | 283,855 | SEC↗ |
| NONE Mallinckrodt plc | A Award deriv | 2025-07-31 | 2025-08-04 | 164,137 | — | $0 | 218,850 | SEC↗ |
| NONE Mallinckrodt plc | M Exercise deriv | 2025-01-01 | 2025-01-02 | 27,355 | — | $0 | 54,713 | SEC↗ |
| NONE Mallinckrodt plc | F Tax w/h | 2025-01-01 | 2025-01-02 | 11,580 | — | $0 | 15,775 | SEC↗ |
| NONE Mallinckrodt plc | M Exercise | 2025-01-01 | 2025-01-02 | 27,355 | — | $0 | 27,355 | SEC↗ |
| NONE Mallinckrodt plc | F Tax w/h | 2025-01-01 | 2025-01-17 | 11,576 | — | $0 | 15,779 | SEC↗ |
| NONE Mallinckrodt plc | A Award deriv | 2024-02-02 | 2024-02-06 | 82,068 | — | $0 | 82,068 | SEC↗ |
| MNKTQ Mallinckrodt plc | D To issuer deriv | 2023-11-14 | 2023-11-16 | 672,948 | — | $0 | 0 | SEC↗ |
| MNKTQ Mallinckrodt plc | D To issuer | 2023-11-14 | 2023-11-16 | 189,863 | — | $0 | 0 | SEC↗ |
| MNK Mallinckrodt plc | F Tax w/h | 2023-06-23 | 2023-06-26 | 38,409 | $1.31 | $50.3K | 189,863 | SEC↗ |
| MNK Mallinckrodt plc | A Award deriv | 2023-04-03 | 2023-04-05 | 672,948 | — | $0 | 672,948 | SEC↗ |
| MNK Mallinckrodt plc | P Buy | 2023-03-13 | 2023-03-15 | 3,000 | $8.37 | $25.1K | 228,272 | SEC↗ |
| MNK Mallinckrodt plc | A Award | 2022-12-14 | 2022-12-22 | 225,272 | — | $0 | 225,272 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 18,000 | — | $0 | 18,000 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2018-05-09 | 2018-05-10 | 18,000 | — | $0 | 18,000 | SEC↗ |
| PFNX Pfenex Inc. | A Award deriv | 2017-05-05 | 2017-05-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ACT Actavis plc | S Sale | 2013-11-11 | 2013-11-13 | 25,000 | $159.87 | $4.00M | 71,947 | SEC↗ |
| ACT Actavis, Inc. | D To issuer | 2013-10-01 | 2013-10-02 | 96,947 | — | $0 | 0 | SEC↗ |
| ACT Actavis plc | A Award | 2013-10-01 | 2013-10-03 | 96,947 | — | $0 | 96,947 | SEC↗ |
| ACT Actavis, Inc. | M Exercise deriv | 2013-09-30 | 2013-10-02 | 150,000 | — | $0 | 0 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-09-30 | 2013-10-02 | 181,845 | $144.00 | $26.19M | 96,947 | SEC↗ |
| ACT Actavis, Inc. | M Exercise | 2013-09-30 | 2013-10-02 | 150,000 | $86.86 | $13.03M | 234,643 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-09-30 | 2013-10-02 | 44,149 | — | $0 | 278,792 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-08-02 | 2013-08-06 | 4,500 | $135.47 | $609.6K | 84,643 | SEC↗ |
| ACT Actavis, Inc. | S Sale | 2013-08-02 | 2013-08-13 | 4,500 | $135.47 | $609.6K | 84,643 | SEC↗ |
| ACT Actavis, Inc. | J Other | 2013-04-08 | 2013-04-10 | 8,163 | — | $0 | 89,143 | SEC↗ |
| ACT Actavis, Inc. | A Award deriv | 2013-03-06 | 2013-03-08 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-03-06 | 2013-03-08 | 8,844 | — | $0 | 73,305 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-03-06 | 2013-03-08 | 7,675 | — | $0 | 80,980 | SEC↗ |
| ACT Actavis, Inc. | F Tax w/h | 2013-03-02 | 2013-03-05 | 3,702 | $85.54 | $316.7K | 64,461 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-10-31 | 2012-11-02 | 14,543 | — | $0 | 68,163 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | F Tax w/h | 2012-09-01 | 2012-09-05 | 811 | $81.35 | $66.0K | 53,620 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-03-08 | 2012-03-12 | 10,027 | — | $0 | 45,878 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-03-08 | 2012-03-12 | 8,553 | — | $0 | 54,431 | SEC↗ |